Body Mass Index and LDL Cholesterol in Relation to PREVENT-HF Risk and Vascular Phenotypes in Treated Hypertension

Background/Objectives: Body mass index (BMI) contributes to estimated heart failure (HF) risk in the Predicting Risk of cardiovascular disease EVENTs (PREVENT) HF equation, whereas cholesterol does not. We examined BMI and low-density lipoprotein cholesterol (LDL-C) associations with calculated risk and measured vascular phenotypes. Methods: This cross-sectional analysis included 158 adults with treated hypertension and no recorded cardiovascular disease or HF. Mutually adjusted models examined seven vascular, renal and inflammatory markers, with robust standard errors and false discovery rate correction across 14 comparisons. Mathematical input-variable substitution scenarios described equation behaviour. Results: Median calculated 10-year HF risk was 4.55% (interquartile range 2.52–8.39%); 44.3% had estimates ≥ 5%. Risk did not differ significantly across BMI categories (p = 0.173). Per 30 mg/dL higher LDL-C, carotid–femoral pulse wave velocity was 0.307 m/s higher, common carotid artery intima–media thickness 0.026 mm higher, flow-mediated dilation 0.277 percentage points lower, reactive hyperaemia index 0.087 lower and capillary density 0.160 loops/mm lower (all q ≤ 0.043). No BMI association passed correction. LDL-C was not significantly correlated with calculated risk after age/sex adjustment (partial ρ = 0.059; p = 0.462). Substituting BMI 25 kg/m2 lowered aggregate calculated risk by 15.0% in obesity, reflecting equation structure. Conclusions: LDL-C was associated with adverse measured vascular phenotypes. These exploratory associations do not demonstrate causality, incremental HF prediction or treatment benefit. Null BMI findings do not exclude adiposity-related vascular effects.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-17
DOI
https://doi.org/10.3390/jcm15229001
Primary Topic
Cardiovascular Health and Disease Prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Body Mass Index and LDL Cholesterol in Relation to PREVENT-HF Risk and Vascular Phenotypes in Treated Hypertension

Ana-Maria Pah, Cristina Tudoran, Simina Crișan, Bogdan Enache et al.
Journal of Clinical Medicine
Cardiovascular Health and Disease Prevention
article

Body Mass Index and LDL Cholesterol in Relation to PREVENT-HF Risk and Vascular Phenotypes in Treated Hypertension

Ana-Maria Pah, Cristina Tudoran, Simina Crișan, Bogdan Enache, Maria Rada, Adina Cristiana Avram, Maria-Laura Craciun
article en

Abstract

Background/Objectives: Body mass index (BMI) contributes to estimated heart failure (HF) risk in the Predicting Risk of cardiovascular disease EVENTs (PREVENT) HF equation, whereas cholesterol does not. We examined BMI and low-density lipoprotein cholesterol (LDL-C) associations with calculated risk and measured vascular phenotypes. Methods: This cross-sectional analysis included 158 adults with treated hypertension and no recorded cardiovascular disease or HF. Mutually adjusted models examined seven vascular, renal and inflammatory markers, with robust standard errors and false discovery rate correction across 14 comparisons. Mathematical input-variable substitution scenarios described equation behaviour. Results: Median calculated 10-year HF risk was 4.55% (interquartile range 2.52–8.39%); 44.3% had estimates ≥ 5%. Risk did not differ significantly across BMI categories (p = 0.173). Per 30 mg/dL higher LDL-C, carotid–femoral pulse wave velocity was 0.307 m/s higher, common carotid artery intima–media thickness 0.026 mm higher, flow-mediated dilation 0.277 percentage points lower, reactive hyperaemia index 0.087 lower and capillary density 0.160 loops/mm lower (all q ≤ 0.043). No BMI association passed correction. LDL-C was not significantly correlated with calculated risk after age/sex adjustment (partial ρ = 0.059; p = 0.462). Substituting BMI 25 kg/m2 lowered aggregate calculated risk by 15.0% in obesity, reflecting equation structure. Conclusions: LDL-C was associated with adverse measured vascular phenotypes. These exploratory associations do not demonstrate causality, incremental HF prediction or treatment benefit. Null BMI findings do not exclude adiposity-related vascular effects.

Journal of Clinical MedicineVol. 15(22)
Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Cardiovascular Health and Disease Prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon